Reference
Akane Y, et al. Successful Treatment with Crizotinib in Refractory Congenital Embryonal Rhabdomyosarcoma with ALK Fusion Gene. Pediatric Blood and Cancer 68 (Suppl. 5): S490 abstr. PO0101/#296, Nov 2021. Available from: URL: http://doi.org/10.1002/pbc.29349 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1883, 45 (2021). https://doi.org/10.1007/s40278-021-06000-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-06000-4